Neurocrine Biosciences, Inc. company logo
Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc. (NBIX) Cash From Operations

Annual CFO

$595.40M$205.50M+52.71%

Summary

Current Value
As of today, NBIX annual cash from operations is $595.40M, up +52.71% on
Historical Performance
NBIX annual cash from operations is up +132.12% over the past 3 years, and up +305.03% over the past 5 years
All-Time High Comparison
NBIX annual cash from operations is currently at its all-time high
3-Year Low Comparison
NBIX annual cash from operations is +75.43% above its 3-year low of $339.40M reached on an earlier date
Sector Comparison
NBIX annual cash from operations is higher than 92.80% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NBIX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations$595.40M+52.7%+132.1%+305.0%+1221.4%
Quarterly Cash From Operations$227.50M+44.0%+130.3%+1400.0%+2121.5%
TTM Cash From Operations$636.80M+33.7%+217.4%+163.0%+1095.3%
Price$140.62+2.2%+14.3%+36.8%+1777.4%
Annual Cash From Investing-$126.80M+72.8%+2.6%+39.9%-1151.7%
Annual Cash From Financing-$486.70M-845.3%-1876.3%-1602.2%-5016.2%
Annual Free Cash Flow$557.20M+54.1%+139.0%+321.2%+1148.8%
Annual CAPEX$38.20M+35.0%+63.3%+159.9%+10000.0%
Annual Net Income$341.30M+36.7%+280.9%+822.1%+768.7%

Cash From Operations Highs

NBIX Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$595.40Mat high
5Y$595.40Mat high
All$595.40Mat high

Cash From Operations Lows

NBIX Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y$339.40MN/A+75.4%
5Y$228.50MN/A+160.6%
All-$106.18M+660.7%

Cash From Operations History

YearValueChange
$595.40M+52.7%
$389.90M+14.9%
$339.40M+32.3%
$256.50M+12.3%
$228.50M+55.4%
$147.00M+45.0%
YearValueChange
$101.40M+207.5%
-$94.33M+11.2%
-$106.18M-179.4%
-$38.00M+19.4%
-$47.14M-

FAQ

  • What is the current annual cash from operations of NBIX?

    As of today, NBIX annual cash from operations is $595.40M

  • What is 1-year change in NBIX annual cash from operations?

    NBIX annual cash from operations is up +52.71% year-over-year

  • What is 3-year change in NBIX annual cash from operations?

    NBIX annual cash from operations is up +132.12% over the past 3 years

  • How far is NBIX annual cash from operations from its all-time high?

    NBIX annual cash from operations is currently at its all-time high

  • How does NBIX annual cash from operations rank versus sector peers?

    NBIX annual cash from operations is higher than 92.80% of companies in Healthcare sector

  • When is NBIX next annual earnings release?

    The next annual earnings release for NBIX is on

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In

Data Sources & References

  1. NBIX Official Website www.neurocrine.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
  4. NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
  5. NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix